Intelligence · Clinical Pipeline
Eli Lilly and Pipeline
All ClinicalTrials.gov programs at Eli Lilly and — phase, modality, and trial IDs.
- Programs
- 21
Quick answer
Eli Lilly and has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
0.9% sodium chloride, GADOTERIC ACID
Eli Lilly Co.
Relapsing Multiple Sclerosis
1 trial -
Abemaciclib, Abemaciclib, Verzenios 50 mg film-coated tablets, TEMOZOLOMIDE
Eli Lilly Co.
Glioma
1 trial -
Abemaciclib, TEMOZOLOMIDE , Verzenios 50 mg film-coated tablets, IRINOTECAN
Eli Lilly Co.
Relapsed/Refractory Solid Tumors
1 trial -
Brenipatide, Brenipatide, Brenipatide, Brenipatide, Placebo to match LY
Eli Lilly Co.
Asthma
1 trial -
Eltrekibart, 0.9% sodium chloride
Eli Lilly Co.
Moderate to Severe Hidradenitis Suppurativa
1 trial -
Eltrekibart, 0.9% sodium chloride, Mirikizumab, Mirikizumab, Placebo for LY3074828 SC Injection, 1mL Prefilled Syringe
Eli Lilly Co.
Ulcerative Colitis
1 trial -
FLORBETAPIR, Placebo to match LY, Flortaucipir, Donanemab
Eli Lilly Co.
Alzheimer Disease
1 trial -
Flortaucipir, Placebo to match LY3372689
Eli Lilly Co.
Alzheimer Disease
1 trial -
IOHEXOL , Placebo to match LY3437943, Retatrutide
Eli Lilly Co.
Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
1 trial -
KEYTRUDA 25 mg/mL concentrate for solution for infusion, CETUXIMAB, olomorasib
Eli Lilly Co.
KRAS G12C-Mutant Advanced Solid Tumors
1 trial -
LY2875358, ERLOTINIB
Eli Lilly Co.
Non-Small Cell Lung Cancer
1 trial -
ONDANSETRON , APREPITANT , PALONOSETRON, COMBINATIONS, PALONOSETRON , Lagipra, GRANISETRON , DEXAMETHASONE , 0.9% sodium chloride
Eli Lilly Co.
Nausea, Drug-Related Side Effects and Adverse Reactions, Vomiting, Neoplasms
1 trial -
Pirtobrutinib, Placebo tablets
Eli Lilly Co.
Immune Thrombocytopenia
1 trial -
Placebo to match LY, Mirikizumab, Placebo to Mirikizumab, Mirikizumab
Eli Lilly Co.
Ulcerative Colitis
1 trial -
Placebo to match LY3540378
Eli Lilly Co.
Heart Failure with Preserved Ejection Fraction, Heart Failure
1 trial -
Placebo to match LY3556050
Eli Lilly Co.
Diabetic Peripheral Neuropathy
1 trial -
Placebo to match LY3848575
Eli Lilly Co.
Neuropathic Pain; Distal Sensory Polyneuropathy
1 trial -
TIRZEPATIDE, TIRZEPATIDE, Placebo to match LY3298176, TIRZEPATIDE, IOHEXOL , TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE
Eli Lilly Co.
Chronic Kidney Disease, CKD, Obesity, Overweight, T2D, Type 2 Diabetes
1 trial -
Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Nisotirotide, placebo to match LY, Tirzepatide
Eli Lilly Co.
Type 2 Diabetes
1 trial -
Verzenios 50 mg film-coated tablets, TAMOXIFEN
Eli Lilly Co.
Metastatic Breast Cancer
1 trial -
Verzenios 50 mg film-coated tablets, TEMOZOLOMIDE , IRINOTECAN , Abemaciclib, Abemaciclib
Eli Lilly Co.
Ewings Sarcoma
1 trial
Frequently asked questions
How many pipeline programs does Eli Lilly and have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs